10 min listen
Psilocybin for Major Depressive Disorder
ratings:
Length:
29 minutes
Released:
Aug 31, 2023
Format:
Podcast episode
Description
In a new study, psilocybin showed promise as a treatment for major depressive disorder (MDD). JAMA Associate Editor Donald C. Goff, MD, speaks with author Charles L. Raison, MD, from the Usona Institute, about the study, as well as Rachel Yehuda, PhD, Mount Sinai School of Medicine, who wrote an accompanying editorial about the potential benefits of psychedelic therapies. Related Content: Single-Dose Psilocybin Treatment for Major Depressive Disorder Psychedelic Therapy—A New Paradigm of Care for Mental Health
Released:
Aug 31, 2023
Format:
Podcast episode
Titles in the series (100)
Discussing Radiation Risks Associated With CT Scans With Patients: Interview with Mark Otto Baerlocher, MD, author of Discussing Radiation Risks Associated With CT Scans With Patients by JAMA Author Interviews